RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 26 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 2,252,964 | $6,804,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,815 | $531,000 | 0.13% |
| THOMPSON DAVIS & CO., INC. | 0 | $9,000 | 0.01% |
| Spark Investment Management LLC | 11,200 | $33,000 | 0.01% |
| Virtu KCG Holdings LLC | 55,599 | $167,000 | 0.00% |
| Ground Swell Capital, LLC | 302 | $1,000 | 0.00% |
| JANE STREET GROUP, LLC | 62,219 | $188,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,668 | $5,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 61 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 11 | $33,000 | 0.00% |